In Vitro Pharmacodynamic Evaluation of Organoids
I. Service Introduction
The in vitro assessment of the efficacy of compounds to be tested against organoid models is a necessary step early in the development of antiviral drugs. Organoid models play an important role in high-throughput drug screening in large compound libraries, detection of single or multi-drug concentrations, rapid discovery of screened drugs, and timely evaluation and optimization of drug effects.
II. Service Cases
· Evaluation of targeted drugs for drug-resistant lung cancer
· ADC drug evaluation for breast cancer
· Colorectal Cancer Clinical Drug Evaluation
· Stomach Cancer Clinical Drug Evaluation
· Ovarian Cancer Clinical Drug Evaluation
· Endometrial Cancer Clinical Drug Evaluation
· Pancreatic Cancer Clinical Drug Evaluation
· Liver Cancer Clinical Drug Evaluation
Case Studies
· Case of Clinical Drug Evaluation Service for Gastric Cancer
· Pancreatic Cancer Clinical Drug Evaluation Service Cases
· Colorectal Cancer Clinical Drug Evaluation Service Cases
· Liver Cancer Clinical Drug Evaluation Service Cases
· Ovarian Cancer Clinical Drug Evaluation Service Cases
OCT002 P2 Acting Drug: Paclitaxel (μM)